<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:xhtml="http://www.w3.org/1999/xhtml">
    <url>
        <loc>https://www.only-orphans-cote.com/blog</loc>
        <priority>1.0</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2025-10-02</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/faq</loc>
        <priority>1.0</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2025-11-20</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/glossary</loc>
        <priority>1.0</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2025-08-05</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/services</loc>
        <priority>1.0</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2025-09-25</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com</loc>
        <priority>1.0</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2026-01-15</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/journal</loc>
        <priority>1.0</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2025-12-11</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/about</loc>
        <priority>1.0</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2026-08-18</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/contact</loc>
        <priority>1.0</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2026-02-04</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/services/fast-track-breakthrough-therapy-designations</loc>
        <priority>1.0</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2025-09-11</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/services/fda-orphan-drug-designation</loc>
        <priority>1.0</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2025-09-11</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/services/ema-orphan-drug-designation</loc>
        <priority>1.0</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2025-09-11</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/services/fda-meetings</loc>
        <priority>1.0</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2025-09-11</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/fast-track-vs-breakthrough-therapy-designation</loc>
        <priority>0.8</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2026-07-30</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/fda-review-structure-orphan-drug-designation</loc>
        <priority>0.8</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2026-06-29</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/orphan-drug-designation-by-the-european-medicines-agency-ema-odd</loc>
        <priority>0.8</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2026-05-22</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/expedited-programs-beyond-orphan-designation</loc>
        <priority>0.8</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2026-06-18</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/rpdd-prv-program-reauthorized-through-2029</loc>
        <priority>0.8</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2026-03-27</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/tropical-disease-priority-review-vouchers-prvs-how-they-workab80d3fc</loc>
        <priority>0.8</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2026-02-23</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/fda-orphan-designation-rare-cancers-eligibility</loc>
        <priority>0.8</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2026-02-04</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/guide-to-ind-enabling-studies</loc>
        <priority>0.8</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2026-02-04</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/deficiency-letters-for-orphan-drug-designation-applications</loc>
        <priority>0.8</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2026-02-04</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/benefits-of-orphan-drug-designation</loc>
        <priority>0.8</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2025-10-30</lastmod>
    </url>
    <url>
        <loc>https://www.only-orphans-cote.com/fda-new-rare-disease-evidence-principles-explained</loc>
        <priority>0.8</priority>
        <changefreq>monthly</changefreq>
        <lastmod>2025-10-30</lastmod>
    </url>
</urlset>
